In this study, we systematically described and statistically analyzed the frequencies and distributions of KRAS/NRAS/BRAF genetic mutation status and their relationship with IHC in 260 cases with colorectal cancer or gastric cancer through retrospective analysis. This evidence concerns the gene NRAS and gastric cancer.